The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
The renin-angiotensin system and malignancy
Open accessAbstract
The renin-angiotensin system (RAS) is usually associated with its systemic action on cardiovascular homoeostasis. However, recent studies suggest that at a local tissue level, the RAS influences tumour growth. The potential of the RAS as a target for cancer treatment and the suggested underlying mechanisms of its paracrine effects are reviewed here. These include modulation of angiogenesis, cellular proliferation, immune responses and extracellular matrix formation. Knowledge of the RAS has increased dramatically in recent years with the discovery of new enzymes, peptides and feedback mechanisms. The local RAS appears to influence tumour growth and metastases and there is evidence of tissue- and tumour-specific differences. Recent experimental studies provide strong evidence that drugs that inhibit the RAS have the potential to reduce cancer risk or retard tumour growth and metastases. Manipulation of the RAS may, therefore, provide a safe and inexpensive anticancer strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Fujiyama, S., Matsubara, H., Nozawa, Y., Maruyama, K., Mori, Y., Tsutsumi, Y., Masaki, H., Uchiyama, Y., Koyama, Y., Nose, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.1.22 · Cited by 202
RetractedBevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
(2024) · Pharmacological Reviews · doi:10.1124/pr · Cited by 2,664
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Dvorak, H. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.088 · Cited by 1,573
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Chen, F., Castranova, V., Shi, X., & Demers, L. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.1.7 · Cited by 718
The renin-angiotensin-aldosterone system: Past, present and future
Vecsei, P., Hackenthal, E., & Ganten, D. (1978) · Klinische Wochenschrift · doi:10.1007/bf01477448 · Cited by 604
Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors
Shaked, Y., Ciarrocchi, A., Franco, M., Lee, C. R., Man, S., Cheung, A. M., Hicklin, D. J., Chaplin, D., Foster, F. S., Benezra, R., et al. (2006) · Science · doi:10.1126/science.1127592 · Cited by 570
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
Lever, A. F., Hole, D. J., Gillis, C. R., McCallum, I. R., McInnes, G. T., MacKinnon, P. L., Meredith, P. A., Murray, L. S., Reid, J. L., & Robertson, J. W. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03228-0 · Cited by 545
Hunyady, L., & Catt, K. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0536 · Cited by 541
Counterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
Shibuya, K., Mathers, C. D., Boschi-Pinto, C., Lopez, A. D., & Murray, C. J. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-37 · Cited by 467
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?
Kerbel, R. S. (2006) · Science · doi:10.1126/science.1125950 · Cited by 466
Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.4.381 · Cited by 445
Angiotensin receptors: a new role in cancer?
Deshayes, F., & Nahmias, C. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.07.009 · Cited by 437
Pettersson, A., Nagy, J. A., Brown, L. F., Sundberg, C., Morgan, E., Jungles, S., Carter, R., Krieger, J. E., Manseau, E. J., Harvey, V. S., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780013 · Cited by 417
YOSHIJI, H., KURIYAMA, S., YOSHII, J., IKENAKA, Y., NOGUCHI, R., NAKATANI, T., TSUJINOUE, H., & FUKUI, H. (2001) · Hepatology · doi:10.1053/jhep.20001.28231 · Cited by 397
Epithelial–mesenchymal transition and tumour invasion
Guarino, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.011 · Cited by 368
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases
Ruiz-Ortega, M., Rupérez, M., Esteban, V., Rodríguez-Vita, J., Sánchez-López, E., Carvajal, G., & Egido, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi265 · Cited by 356
Bataller, R., Sancho-bru, P., Ginès, P., Lora, J. M., Al-garawi, A., Solé, M., Colmenero, J., Nicolás, J. M., Jiménez, W., Weich, N., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00695-4 · Cited by 352
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth
Egami, K., Murohara, T., Shimada, T., Sasaki, K.-I., Shintani, S., Sugaya, T., Ishii, M., Akagi, T., Ikeda, H., Matsuishi, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16645 · Cited by 345
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M., et al. (2005) · Gut · doi:10.1136/gut.2004.062398 · Cited by 334
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.913 · Cited by 301
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
Freeman, E. J., Chisolm, G. M., Ferrario, C. M., & Tallant, E. A. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.104 · Cited by 295
Tumor Angiogenesis: A Possible Control Point in Tumor Growth
FOLKMAN, J. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-1-96 · Cited by 278
Macrophage Infiltration and Heme Oxygenase-1 Expression Correlate with Angiogenesis in Human Gliomas
西江, 昭. (2001) · Medical Entomology and Zoology · doi:10.11501/3181003 · Cited by 278
Suganuma, T., Ino, K., Shibata, K., Kajiyama, H., Nagasaka, T., Mizutani, S., & Kikkawa, F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1946 · Cited by 237
Angiotensin II and vascular inflammation.
Cheng, Z. J., Vapaatalo, H., & Mervaala, E. M. A. (2005) · PubMed · Cited by 236
Levy, B. I., Benessiano, J., Henrion, D., Caputo, L., Heymes, C., Duriez, M., Poitevin, P., & Samuel, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118807 · Cited by 233
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
Fujita, M., Hayashi, I., Yamashina, S., Itoman, M., & Majima, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00496-5 · Cited by 233
Los, M., Roodhart, J. M. L., & Voest, E. E. (2007) · The Oncologist · doi:10.1634/theoncologist.12-4-443 · Cited by 229
Tamarat, R., Silvestre, J.-S., Durie, M., & Levy, B. I. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000017372.76297.eb · Cited by 227
Wolf, G., Wenzel, U., Burns, K. D., Harris, R. C., Stahl, R. A. K., & Thaiss, F. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00365.x · Cited by 226
Obstructive nephropathy: Insights from genetically engineered animals
Bascands, J.-L., & Schanstra, J. P. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00486.x · Cited by 216
Yoshiji, H., Kuriyama, S., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., & Fukui, H. (2001) · PubMed · Cited by 211
Cytokine networks in solid human tumors: regulation of angiogenesis
Leek, R. D., Harris, A. L., & Lewis, C. E. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.4.423 · Cited by 207
Histological categorisation of fibrotic cancer stroma in advanced rectal cancer
Ueno, H., Jones, A. M., Wilkinson, K. H., Jass, J. R., & Talbot, I. C. (2004) · Gut · doi:10.1136/gut.2003.028365 · Cited by 199
The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
Klahr, S., & Morrissey, J. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07509.x · Cited by 194
Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart.
López Farré, A., Riesco, A., Espinosa, G., Digiuni, E., Cernadas, M. R., Alvarez, V, Montón, M., Rivas, F., Gallego, M. J., & Egido, J. (1993) · Circulation · doi:10.1161/01.cir.88.3.1166 · Cited by 192
Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer
Kamat, A. A., Merritt, W. M., Coffey, D., Lin, Y. G., Patel, P. R., Broaddus, R., Nugent, E., Han, L. Y., Landen, C. N., Spannuth, W. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1017 · Cited by 192
Up-regulation of components of the renin-angiotensin system in the bile duct–ligated rat liver
Paizis, G., Cooper, M. E., Schembri, J. M., Tikellis, C., Burrell, L. M., & Angus, P. W. (2002) · Gastroenterology · doi:10.1053/gast.2002.36561 · Cited by 189
Uemura, H., Ishiguro, H., Nakaigawa, N., Nagashima, Y., Miyoshi, Y., Fujinami, K., Sakaguchi, A., & Kubota, Y. (2003) · PubMed · Cited by 188
Gallagher, P. E., Chappell, M. C., Ferrario, C. M., & Tallant, E. A. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00409.2004 · Cited by 185
Nonclassic Endogenous Novel Regulators of Angiogenesis
Ribatti, D., Conconi, M. T., & Nussdorfer, G. G. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.3 · Cited by 178
Silvestre, J.-S., Bergaya, S., Tamarat, R., Duriez, M., Boulanger, C. M., & Levy, B. I. (2001) · Circulation Research · doi:10.1161/hh2001.097691 · Cited by 175
Angiotensin Ii Receptor Blockers
Barreras, A., & Gurk-Turner, C. (2003) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2003.11927893 · Cited by 174
Endothelin-1 Promotes Epithelial-to-Mesenchymal Transition in Human Ovarian Cancer Cells
Rosanò, L., Spinella, F., Di Castro, V., Nicotra, M. R., Dedhar, S., de Herreros, A. G., Natali, P. G., & Bagnato, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2123 · Cited by 173
Transforming growth factor-β gene expression in normal and fibrotic rat liver
De Bleser, P. J., Niki, T., Rogiers, V., & Geerts, A. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80257-7 · Cited by 169
Miyajima, A., Kosaka, T., Asano, T., Asano, T., Seta, K., Kawai, T., & Hayakawa, M. (2002) · PubMed · Cited by 158
Liver Fibrogenesis: A New Role for the Renin–Angiotensin System
Bataller, R. A., Sancho‐Bru, P., Ginès, P., & Brenner, D. A. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1346 · Cited by 155
Herath, C. B., Warner, F. J., Lubel, J. S., Dean, R. G., Jia, Z., Lew, R. A., Smith, A. I., Burrell, L. M., & Angus, P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.008 · Cited by 154
Angiotensin-converting enzyme inhibitors and the risk of cancer
Friis, S., Sørensen, H. T., Mellemkjøer, L., McLaughlin, J. K., Nielsen, G. L., Blot, W. J., & Olsen, J. H. (2001) · Cancer · Cited by 153
Koh, W., Yuan, J., Sun, C., Berg, D. V. D., Seow, A., Lee, H.-P., & Yu, M. C. (2003) · PubMed · Cited by 153
Pupilli, C., Lasagni, L., Romagnani, P., Bellini, F., Mannelli, M., Misciglia, N., Mavilia, C., VELLEI, U., Villari, D., & Serio, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v102245 · Cited by 151
Bayón, L. G., Izquierdo, M. A., Sirovich, I., van Rooijen, N., Beelen, R. H. J., & Meijer, S. (1996) · Hepatology · doi:10.1002/hep.510230542 · Cited by 150
Cao, Y. (2004) · The biomedical & life sciences collection. · doi:10.1016/j.semcancer.2003.09.018 · Cited by 148
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions
Ozawa, Y., Kobori, H., Suzaki, Y., & Navar, L. G. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00059.2006 · Cited by 147
Kawahara, Y., Sunako, M., Tsuda, T., Fukuzaki, H., Fukumoto, Y., & Takai, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90485-8 · Cited by 144
Sarlos, S., Rizkalla, B., Moravski, C. J., Cao, Z., Cooper, M. E., & Wilkinson‐Berka, J. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63448-7 · Cited by 140
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options
Gressner, O. A., Weiskirchen, R., & Gressner, A. M. (2007) · Comparative Hepatology · doi:10.1186/1476-5926-6-7 · Cited by 137
van der Knaap, R., Siemes, C., Coebergh, J. W. W., van Duijn, C. M., Albert Hofman, D., & Stricker, B. H. C. (2008) · Cancer · doi:10.1002/cncr.23215 · Cited by 134
Mechanisms of Disease: the tissue kallikrein–kinin system in hypertension and vascular remodeling
Madeddu, P. R., Emanueli, C., & El-Dahr, S. S. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0444 · Cited by 133
Prendergast, G. C. (2004) · Wiley eBooks · doi:10.1002/047165616x · Cited by 129
Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma
Hii, S.-I., Nicol, D. L., Gotley, D. C., Thompson, L. C., Green, M. K., & Jonsson, J. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.145 · Cited by 129
Neo, J. H., Malcontenti‐Wilson, C., Muralidharan, V., & Christophi, C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04797.x · Cited by 127
Self-citationBenndorf, R. A., Böger, R. H., Ergün, S., Steenpaß, A., & Wieland, T. (2003) · Circulation Research · doi:10.1161/01.res.0000088358.99466.04 · Cited by 123
Groß, O., Schulze-Lohoff, E., Koepke, M.-L., Beirowski, B., Addicks, K., Bloch, W., Smyth, N. R., & Weber, M. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh219 · Cited by 117
Angiotensin II Receptor Inhibition
Messerli, F. H. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440160069010 · Cited by 117
Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer
Meier, C. R., Derby, L. E., Jick, S. S., & Jick, H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.3.349 · Cited by 116
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
Yang, L., Bataller, R. A., Dulyx, J., Coffman, T. M., Ginès, P., Rippe, R. A., & Brenner, D. A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.034 · Cited by 114
Association between captopril, other antihypertensive drugs and risk of prostate cancer
Ronquist, G., Rodríguez, L. A. G., Ruigómez, A., Johansson, S., Wallander, M.-A. A., Frithz, G., & Svärdsudd, K. (2003) · The Prostate · doi:10.1002/pros.10294 · Cited by 113
Mice with Enhanced Macrophage Angiotensin-Converting Enzyme Are Resistant to Melanoma
Shen, X. Z., Li, P., Weiss, D., Fuchs, S., Xiao, H., Adams, J. A., Williams, I. R., Capecchi, M. R., Taylor, W. R., & Bernstein, K. E. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061205 · Cited by 111
Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes.
Otani, A., Takagi, H., Oh, H., Suzuma, K., Matsumura, M., Ikeda, E., & Honda, Y. (2000) · PubMed · Cited by 109
Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells
Heuff, G., Oldenburg, H. S. A., Boutkan, H., Visser, J. J., Beelen, R. H. J., van Rooijen, N., Dijkstra, C. D., & Meyer, S. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01517045 · Cited by 108
Silvestre, J., Tamarat, R., Senbonmatsu, T., Icchiki, T., Ebrahimian, T. G., Iglarz, M., Besnard, S., Duriez, M., Inagami, T., & Levy, B. I. (2002) · Circulation Research · doi:10.1161/01.res.0000019892.41157.24 · Cited by 108
Cancer, inflammation and the AT1 and AT2 receptors.
Smith, G. R., & Missailidis, S. (2004) · Journal of Inflammation · doi:10.1186/1476-9255-1-3 · Cited by 104
Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer
Kosaka, T., Miyajima, A., Takayama, E., Kikuchi, E., Nakashima, J., Ohigashi, T., Asano, T., Sakamoto, M., Okita, H., Murai, M., et al. (2006) · The Prostate · doi:10.1002/pros.20486 · Cited by 95
Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery
Bouzin, C., & Féron, O. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.03.001 · Cited by 95
Tea, B.-S., Sarkissian, S. D., Touyz, R. M., Hamet, P., & deBlois, D. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1069 · Cited by 95
Röcken, C., Lendeckel, U., Dierkes, J., Westphal, S., Carl‐McGrath, S., Peters, B., Krüger, S., Malfertheiner, P., Roessner, A., & Ebert, M. P. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1922 · Cited by 93
Opposing actions of angiotensins on angiogenesis
Machado, R. D. P., Santos, R. A. S., & Andrade, S. P. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00562-7 · Cited by 93
AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma
Rivera, E., Arrieta, O. G., Guevara, P., Duarte‐Rojo, A., & Sotelo, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2102 · Cited by 89
Yasumatsu, R., Nakashima, T., Masuda, M., Ito, A., Kuratomi, Y., Nakagawa, T., & Komune, S. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0582-7 · Cited by 87
Tamarat, R., Silvestre, J., Kubis, N., Bénessiano, J., Duriez, M., deGasparo, M., Henrion, D., & Levy, B. I. (2002) · Hypertension · doi:10.1161/hy0302.104671 · Cited by 85
Zhang, X., Lassila, M., Cooper, M. E., & Cao, Z. (2004) · Hypertension · doi:10.1161/01.hyp.0000113628.94574.0f · Cited by 84
Angiotensin II and extracellular matrix homeostasis
Weber, K. T., Swamynathan, S. K., Guntaka, R. V., & Sun, Y. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00125-3 · Cited by 81
Regland, B., Blennow, K., Germgård, T., Koch-Schmidt, A.-C., & Gottfries, C. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017127 · Cited by 76
Barr, M. P., Bouchier-Hayes, D., & Harmey, J. H. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.1.41 · Cited by 76
The renin–angiotensin system contributes to renal fibrosis through regulation of fibrocytes
Sakai, N., Wada, T., Matsushima, K., Bucala, R., Iwai, M., Horiuchi, M., & Kaneko, S. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f3e9e6 · Cited by 75
Mechanisms of angiotensin-(1–7)-induced inhibition of angiogenesis
Machado, R. D. P., Santos, R. A. S., & Andrade, S. P. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.4.r994 · Cited by 72
Nogueira, E. F., Vargas, C. A., Otis, M., Gallo‐Payet, N., Bollag, W. B., & Rainey, W. E. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0094 · Cited by 70
Paepe, B. D., Verstraeten, V. L. R. M., Potter, C. R. D., & Bullock, G. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0356-0 · Cited by 69
Sonveaux, P. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.01.024 · Cited by 62
Ellefson, D. D., diZerega, G. S., Espinoza, T. B., Roda, N., Maldonado, S., & Rodgers, K. E. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0710-0 · Cited by 61
Endothelial Progenitor Cell Differentiation and Senescence in an Angiotensin II-Infusion Rat Model
Kobayashi, K., Imanishi, T., & Akasaka, T. (2006) · Hypertension Research · doi:10.1291/hypres.29.449 · Cited by 60
Liu, H., Wei, X., Sun, R. B., Cai, Y., Lou, H., Wang, J., Chen, A. F., & Zhang, X. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.049 · Cited by 56
Effect of Losartan, an Angiotensin II Antagonist, on Hepatic Fibrosis Induced by CCl4 in Rats
Wei, Y. H., Li, J., & Qiang, C. J. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000043369.88701.5b · Cited by 55
Pearson, H. J., Anderson, J., Chamberlain, J., & Bell, P. R. F. (1986) · Cancer Immunology Immunotherapy · doi:10.1007/bf00205652 · Cited by 53
Shen, X. Z., Lukacher, A. E., Billet, S., Williams, I. R., & Bernstein, K. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709574200 · Cited by 49
Bates, R. C., Pursell, B. M., & Mercurio, A. M. (2007) · Cells Tissues Organs · doi:10.1159/000101300 · Cited by 48
Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+
Zhang, W., Zhou, J., & Ye, Q.-J. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.008 · Cited by 44
LOCKWOOD, D. S., YEADON, T. M., CLOUSTON, A. D., CRAWFORD, D. G., FAWCETT, J., CALLAGHAN, S. A., & GOTLEY, D. C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03018.x · Cited by 44
Perindopril: possible use in cancer therapy
Yoshiji, H., Kuriyama, S., & Fukui, H. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200203000-00003 · Cited by 39
Trotter, M. J., Chaplin, D. J., & Olive, P. L. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90140-9 · Cited by 32
Expression of connective tissue growth factor in pancreatic cancer cell lines
Kwon, S. W., Munroe, X., Crawley, S., Lee, H. J., Spong, S. M., Bradham, D. M., Gum, J. R., Sleisenger, M. H., & Kim, Y. S. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.4.693 · Cited by 31
Tone, A., Shikata, K., Ogawa, D., Sasaki, S., Nagase, R., Sasaki, M., Yozai, K., Usui, H. K., Okada, S., Wada, J., et al. (2007) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2007.007 · Cited by 27
Yayama, K., Sugiyama, K., Miyagi, R., & Okamoto, H. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.591 · Cited by 26
Holtz, D. O., Krafty, R. T., Mohamed-Hadley, A. A., Zhang, L., Alagkiozidis, I., Leiby, B. E., Guo, W., Gimotty, P. A., & Coukos, G. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-2 · Cited by 24
Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: The role of ALDH-2
Zhang, G., Shi, R., Jiang, D., Chen, Y.-R., Jia-Chen, Tang, Z., Bai, Y., Xiao, H., & Li, Y. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.002 · Cited by 18
Pawlikowski, M. (2006) · PubMed · Cited by 17
Ishizaka, N., Matsuzaki, G., Saito, K., Noiri, E., Mori, I., & Nagai, R. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700486 · Cited by 14
Bascands, J., & Schanstra, J. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000143721.71748.30 · Cited by 11
ACE inhibitors, angiotensin receptor antagonists and bradykinin
Schächter, M. (2000) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2000.005 · Cited by 7
Cited by
Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733
The renin–angiotensin system and cancer: old dog, new tricks
George, A. J., Thomas, W. G., & Hannan, R. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2945 · Cited by 525
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Pinter, M., & Jain, R. K. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5616 · Cited by 332
The role of kinin receptors in cancer and therapeutic opportunities
da Costa, P. L. N., Sirois, P., Tannock, I. F., & Chammas, R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.009 · Cited by 133
“Several studies have revealed that ACE inhibitors (ACEi) reduce growth and angiogenesis of experimental tumors [3,113,174,181,186].”
Background
Metadata
- Authors
- Ager, E. I., Neo, J., & Christophi, C.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-09
- Volume
- 29
- Issue
- 9
- Pages
- 1675-1684
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2142080475
- Cited by
- 295
- References
- 121
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.